QC
CRL icon

Quadrature Capital’s Charles River Laboratories CRL Stock Holding History

Quadrature Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,837
Closed -$1.36M – 1457
2025
Q4 		$1.36M Sell
6,837
-3,014
-31% -$547K 0.01% 451
2025
Q3 		$1.54M Sell
9,851
-8,131
-45% -$1.29M 0.02% 334
2025
Q2 		$2.73M Buy
+17,982
New +$2.4M 0.05% 248
2025
Q1 		– Sell
-10,215
Closed -$1.88M – 1132
2024
Q4 		$1.88M Buy
10,215
+6,745
+194% +$1.3M 0.04% 316
2024
Q3 		$683K Sell
3,470
-41,941
-92% -$8.72M 0.02% 435
2024
Q2 		$9.38M Buy
45,411
+38,960
+604% +$8.83M 0.16% 127
2024
Q1 		$1.75M Buy
+6,451
New +$1.54M 0.03% 332
2022
Q4 		– Sell
-48,638
Closed -$9.59M – 893
2022
Q3 		$9.59M Buy
48,638
+1,924
+4% +$415K 0.31% 88
2022
Q2 		$10M Buy
46,714
+36,024
+337% +$8.8M 0.42% 66
2022
Q1 		$3.04M Buy
+10,690
New +$3.3M 0.12% 144
2021
Q1 		– Sell
-900
Closed -$225K – 912
2020
Q4 		$225K Buy
+900
New +$214K 0.01% 687
2020
Q3 		– Sell
-3,700
Closed -$645K – 765
2020
Q2 		$645K Buy
+3,700
New +$591K 0.07% 332
2017
Q2 		– Sell
-8,553
Closed -$770K – 591
2017
Q1 		$770K Sell
8,553
-15,723
-65% -$1.34M 0.06% 331
2016
Q4 		$1.85M Buy
+24,276
New +$1.84M 0.06% 303

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Quadrature Capital's CRL Position: Q1 2026 in Review

Quadrature Capital sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 6,837 shares — an estimated $1.36M sold.

Quadrature Capital first reported a position in CRL in Q4 2016 and held it in 14 quarters. The position peaked at $10M in Q2 2022. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Quadrature Capital reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 6,837 Charles River Laboratories shares in Q1 2026, an estimated $1.36M.
  • Quadrature Capital first reported a position in Charles River Laboratories in Q4 2016 and held it in 14 quarters.
  • Quadrature Capital's Charles River Laboratories position peaked at $10M in Q2 2022.
  • 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.